Table 3.

Stop time points of TNFi for patients with and without detectable TNFi in the cord blood

	Stop time point if TNFi was detectable, GA, weeks	Stop time point if TNFi was undetectable, GA, weeks	P value for difference
Certolizumab pegol (n=68)	36.9 (34.8–38.6)	37.0 (34.1–38.1)	0.82
Etanercept* (n=30)	–	–	–
Adalimumab (n=25)	19.4 (18.7–20.1)	15.0 (4.4–18.8)	0.08
Infliximab (n=14)	19.1 (16.7–20.3)	13.6 (6.9–18.4)	0.06

*Etanercept was not detectable in any of the cord blood samples.

GA, gestational age; TNF, tumour necrosis factor.